JMDC Inc
TSE:4483
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Feitian Technologies Co Ltd
SZSE:300386
|
CN |
JMDC Inc
Other Current Assets
JMDC Inc
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
JMDC Inc
TSE:4483
|
Other Current Assets
¥1.4B
|
CAGR 3-Years
23%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
M3 Inc
TSE:2413
|
Other Current Assets
¥12.4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
20%
|
CAGR 10-Years
21%
|
|
|
S
|
Software Service Inc
TSE:3733
|
Other Current Assets
¥635m
|
CAGR 3-Years
33%
|
CAGR 5-Years
18%
|
CAGR 10-Years
19%
|
|
|
Medley Inc
TSE:4480
|
Other Current Assets
¥771m
|
CAGR 3-Years
27%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
CareNet Inc
TSE:2150
|
Other Current Assets
¥657.6m
|
CAGR 3-Years
56%
|
CAGR 5-Years
44%
|
CAGR 10-Years
24%
|
|
|
Medical Data Vision Co Ltd
TSE:3902
|
Other Current Assets
¥499.4m
|
CAGR 3-Years
23%
|
CAGR 5-Years
17%
|
CAGR 10-Years
24%
|
|
JMDC Inc
Glance View
Amidst the complex intersection of healthcare and technology, JMDC Inc. has carved a unique niche by harnessing the power of big data to improve healthcare outcomes and efficiency. Founded in Japan, the company stands as a beacon in the health informatics sector, meticulously collecting and analyzing health-related data drawn from a variety of sources, including medical claims, health screenings, and electronic health records. By transforming this extensive data trove into actionable insights, JMDC offers healthcare providers, pharmaceutical companies, and insurance firms the analytics they need to make informed decisions. Key to JMDC's operation is its commitment to safeguarding patient anonymity while extracting valuable insights that can streamline healthcare delivery, enhance pharmaceutical research, and optimize insurance underwriting. JMDC's revenue model hinges on the sale of its aggregated data and analytics solutions to a vast array of stakeholders in the medical field. Pharmaceutical companies, eager to understand drug efficacy and patient demographics better, turn to JMDC for data-driven insights that can influence drug development and marketing strategies. Insurance companies leverage JMDC's data to refine their offerings and better assess risk, ensuring competitive pricing models and improved customer satisfaction. Moreover, healthcare providers utilize this analytics backbone to enhance operational efficiency and improve patient care outcomes. Through licensing agreements and subscription-based services, JMDC effectively monetizes its data resources, achieving sustained growth in an industry that increasingly values the marriage of technology and healthcare.
See Also
What is JMDC Inc's Other Current Assets?
Other Current Assets
1.4B
JPY
Based on the financial report for Dec 31, 2025, JMDC Inc's Other Current Assets amounts to 1.4B JPY.
What is JMDC Inc's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
27%
Over the last year, the Other Current Assets growth was 35%. The average annual Other Current Assets growth rates for JMDC Inc have been 23% over the past three years , 27% over the past five years .